11 Healthcare Stocks Moving In Monday's Pre-Market Session

Gainers

• Seattle Genetics, Inc. SGEN stock increased by 9.8% to $96.00 during Monday's pre-market session. The market cap stands at $14.5 billion. The most recent rating by Oppenheimer, on October 01, is at Outperform, with a price target of $92.00.
• Avinger, Inc. AVGR stock increased by 8.1% to $1.20. The market value of their outstanding shares is at $8.4 million.
• Titan Pharmaceuticals, Inc. TTNP stock moved upwards by 6.9% to $0.19. The market value of their outstanding shares is at $4.2 million.
• Foamix Pharmaceuticals, Inc. FOMX shares increased by 4.6% to $3.30. The market cap stands at $185.4 million. The most recent rating by H.C. Wainwright, on October 21, is at Buy, with a price target of $11.00.

Losers

• Clearside Biomedical, Inc. CLSD stock declined 11.0% to $0.73 during Monday's pre-market session. The market cap seems to be at $26.0 million.
• Endo International, Inc. ENDP shares fell 9.7% to $4.40. The market cap stands at $715.3 million.
• Mallinckrodt, Inc. MNK shares declined 7.9% to $2.45. The market value of their outstanding shares is at $202.4 million. The most recent rating by Stifel, on September 09, is at Hold, with a price target of $8.00.
• Smith & Nephew, Inc. SNN stock fell 7.6% to $44.15.
• Teva Pharmaceutical Indus, Inc. TEVA stock declined 2.3% to $7.33. According to the most recent rating by Gabelli & Co., on October 17, the current rating is at Buy.
• Bionano Genomics, Inc. BNGO shares decreased by 1.1% to $1.88. The market cap seems to be at $7.8 million.
• Qiagen, Inc. QGEN shares declined 1.0% to $28.21. The market value of their outstanding shares is at $7.4 billion. According to the most recent rating by Kepler Cheuvreux, on October 09, the current rating is at Reduce.